(Total Views: 419)
Posted On: 04/17/2020 11:29:57 AM
Post# of 153981
Everyone needs to take a deep breath.
COVID is an opportunity, but its not WHO Cytodyn is. I hope we can capitalize on it, but if we are too late, we are too late. I do think in the end we will be shown to be superior to Resdemivir. And likely we will be used to treat some number of COVID patients, and we could become the standard of care for other ARDS.
At this point, my entire focus is on enrollment. Enrollment for COVID and for Cancer.
COVID is an opportunity, but its not WHO Cytodyn is. I hope we can capitalize on it, but if we are too late, we are too late. I do think in the end we will be shown to be superior to Resdemivir. And likely we will be used to treat some number of COVID patients, and we could become the standard of care for other ARDS.
At this point, my entire focus is on enrollment. Enrollment for COVID and for Cancer.
(8)
(0)
